Compare, Analyse with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN PHARMACEUTICALS   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
ADCOCK INGRAM
Jun-14
SUVEN PHARMACEUTICALS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs525372-   
Low Rs103268-   
Sales per share (Unadj.) Rs39.7110.6-  
Earnings per share (Unadj.) Rs12.1-27.9-  
Cash flow per share (Unadj.) Rs13.4-23.1-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs46.486.8-  
Shares outstanding (eoy) m254.57168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.92.9 273.7%   
Avg P/E ratio x25.9-11.5 -225.6%  
P/CF ratio (eoy) x23.5-13.9 -169.6%  
Price / Book Value ratio x6.83.7 183.7%  
Dividend payout %16.50-   
Avg Mkt Cap Rs m79,95354,029 148.0%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7623,391 22.5%   
Avg. sales/employee Rs ThNM4,349.7-  
Avg. wages/employee Rs ThNM789.9-  
Avg. net profit/employee Rs ThNM-1,096.0-  
INCOME DATA
Net Sales Rs m10,09718,673 54.1%  
Other income Rs m142131 108.9%   
Total revenues Rs m10,24018,804 54.5%   
Gross profit Rs m4,430-3,236 -136.9%  
Depreciation Rs m316806 39.3%   
Interest Rs m117506 23.1%   
Profit before tax Rs m4,139-4,417 -93.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,053276 381.6%   
Profit after tax Rs m3,086-4,705 -65.6%  
Gross profit margin %43.9-17.3 -253.2%  
Effective tax rate %25.4-6.2 -407.2%   
Net profit margin %30.6-25.2 -121.3%  
BALANCE SHEET DATA
Current assets Rs m6,66513,677 48.7%   
Current liabilities Rs m3,2157,695 41.8%   
Net working cap to sales %34.232.0 106.7%  
Current ratio x2.11.8 116.6%  
Inventory Days Days200111 180.2%  
Debtors Days Days370124 298.6%  
Net fixed assets Rs m9,0977,972 114.1%   
Share capital Rs m25587 293.6%   
"Free" reserves Rs m11,5540-   
Net worth Rs m11,80814,656 80.6%   
Long term debt Rs m3565,151 6.9%   
Total assets Rs m15,76227,687 56.9%  
Interest coverage x36.5-7.7 -471.9%   
Debt to equity ratio x00.4 8.6%  
Sales to assets ratio x0.60.7 95.0%   
Return on assets %20.3-15.2 -134.0%  
Return on equity %26.1-32.1 -81.4%  
Return on capital %35.0-19.8 -176.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5330-   
CASH FLOW
From Operations Rs m3,8341,594 240.6%  
From Investments Rs m-3,114-489 636.3%  
From Financial Activity Rs m-7664,674 -16.4%  
Net Cashflow Rs m-455,779 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.13 Rs / ZAR

Compare SUVEN PHARMACEUTICALS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUVEN PHARMACEUTICALS With: KAMRON LABORATORIES  DESH RAKSHAK  BAFNA PHARMA  HINDUSTAN BIOSCIE  MESCO PHARMA  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You... (Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally (Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN PHARMACEUTICALS SHARE PRICE


Oct 22, 2021 (Close)

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 8-QTR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

FEATURED VIDEOS

Why a Simple Portfolio Beat Quality Bluechips by 2x

How to Pick Multibagger Stocks

IRCTC: Buy, Hold or Sell

What to Look for in an IPO

More Featured Videos

MARKET STATS